🌟 Happy International Women's Day from Circumvent! 🌟 Today, we celebrate the remarkable women who drive our success and inspire us daily. Your talent, leadership, and dedication make Circumvent a better place. Cheers to you all for making a difference! 💪🎉 #IWD #Circumvent #EmpowerWomen
About us
Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Circumvent is funded by NIH/NINDS, YC Bio, Heritage Provider Network, and the Longevity Fund
- Website
-
http://www.circumventpharmaceuticals.com
External link for Circumvent
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Portland, Oregon
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Small molecule therapy, Batten Disease, INCL, and Neurodegeneration
Locations
-
Primary
Get directions
Portland, Oregon, US
Employees at Circumvent
-
Paul Rudnick
Bioinformatics Scientist / Entrepreneur
-
Daniel Chelsky
Chief Scientific Officer at Circumvent
-
Misty Kuryliw
Research Professional
-
Anna Scott
Director of the Biochemical Genetics Lab at Seattle Children's; Assistant Professor, Department of Laboratory Medicine and Pathology at University of…